Targeted OUM1/PTPRZ1 silencing and synergetic CDT/enhanced chemical therapy toward uveal melanoma based on a dual-modal imaging-guided manganese metal–organic framework nanoparticles
Open Access
- 5 November 2022
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 20 (1) , 1-21
Abstract
Metastasis and chemical resistance are the most serious problems in the treatment of highly aggressive uveal melanoma (UM). The newly identified lncRNA OUM1 is overexpressed in UM, functions as a catalyst and regulates protein tyrosine phosphatase (PTP) activity by binding to PTP receptor type Z1 (PTPRZ1), which plays an important role in cell proliferation, metastasis and chemotherapy resistance in the UM microenvironment. Hence, siRNAs that selectively knocking down the lncRNA OUM1 (siOUM1) and its target gene PTPRZ1 (siPTPRZ1) were designed to inhibit the OUM1/PTPRZ1 pathway to reduce PTP activity, and this reduction in activity interrupts protein tyrosine phosphorylation, suppresses UM proliferation and metastasis and improves cisplatin sensitivity in UM cells. Then, to overcome the limitations of the difficulty of drug administration and traditional therapeutics, the indocyanine green (ICG)-labeled manganese metal–organic framework (MOF) nanoparticles (NPs) were fabricated and linked with arginine-glycine-aspartate (RGD) peptide to carry siOUM1/siPTPRZ1 and cisplatin to achieve targeted siRNA interference-mediated therapy, enhanced cisplatin therapy and chemodynamic therapy. This NP system also has a dual-modal imaging ability because ICG is a near-infrared region fluorescent dye and manganese has the potential to be used in magnetic resonance imaging. This study verifies the significance of the newly discovered lncRNA OUM1 as a new therapeutic target for aggressive UM and provides a drug delivery NP system for precise treatment of UM accompanied with a dual-modal imaging ability. Graphical AbstractKeywords
Funding Information
- National Natural Science Foundation of China (81972524 and 81602366)
- Science and Technology Commission of Shanghai Municipality (17DZ2260100)
- Ninth People’s Hospital Affiliated to Medical College of Shanghai Jiaotong University (SYZ2015-010)
- Shanghai “Rising Stars of Medical Talent” Youth Development Program, Youth Medical Talents-Specialist Program
This publication has 45 references indexed in Scilit:
- Management of Posterior Uveal Melanoma: Past, Present, and FutureOphthalmology, 2015
- Epigenetic regulation in human melanoma: past and futureEpigenetics, 2015
- Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma PatientsAmerican Journal of Ophthalmology, 2014
- Dual Bioresponsive Mesoporous Silica Nanocarrier as an “AND” Logic Gate for Targeted Drug Delivery Cancer CellsAdvanced Functional Materials, 2014
- The rise of regulatory RNANature Reviews Genetics, 2014
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expressionProceedings of the National Academy of Sciences, 2009
- Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammalsNature, 2009
- Protein tyrosine phosphatases in signalingCurrent Opinion in Cell Biology, 1996
- Extracellular pH distribution in human tumoursInternational Journal of Hyperthermia, 1995